QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Abstract Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (96) Citing Articles via Google Scholar Google Scholar Articles by Sur, C. Articles by Rosahl, T. W. Search for Related Content PubMed PubMed Citation Articles by Sur, C. Articles by Rosahl, T. W.

 Previous Article  |  Next Article 

The Journal of Neuroscience, May 15, 2001, 21(10):3409-3418

Loss of the Major GABA_A Receptor Subtype in the Brain Is Not Lethal in Mice

Cyrille Sur, Keith A. Wafford, David S. Reynolds, Karen L. Hadingham, Frances Bromidge, Alison Macaulay, Neil Collinson, Gillian O'Meara, Owain Howell, Richard Newman, Janice Myers, John R. Atack, Gerard R. Dawson, Ruth M. McKernan, Paul J. Whiting, and Thomas W. Rosahl

Neuroscience Research Center, Merck Sharp and Dohme Research Laboratories, Harlow, Essex, CM20 2QR, United Kingdom

	ABSTRACT

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

The 122 is the most abundant subtype of the GABA_A receptor and is localized in many regions of the brain. To gain more insight into the role of this receptor subtype in the modulation of inhibitory neurotransmission, we generated mice lacking either the 1 or 2 subunit. In agreement with the reported abundance of this subtype, >50% of total GABA_A receptors are lost in both 1/ and 2/ mice. Surprisingly, homozygotes of both mouse lines are viable, fertile, and show no spontaneous seizures. Initially half of the 1/ mice died prenatally or perinatally, but they exhibited a lower mortality rate in subsequent generations, suggesting some phenotypic drift and adaptive changes. Both adult 1/ and 2/ mice demonstrate normal performances on the rotarod, but 2/ mice displayed increased locomotor activity. Purkinje cells of the cerebellum primarily express 122 receptors, and in electrophysiological recordings from 1/ mice GABA currents in these neurons are dramatically reduced, and residual currents have a benzodiazepine pharmacology characteristic of 2- or 3-containing receptors. In contrast, the cerebellar Purkinje neurons from 2/ mice have only a relatively small reduction of GABA currents. In 2/ mice expression levels of all six  subunits are reduced by ~50%, suggesting that the 2 subunit can coassemble with  subunits other than just 1. Our data confirm that 122 is the major GABA_A receptor subtype in the murine brain and demonstrate that, surprisingly, the loss of this receptor subtype is not lethal.

Key words: GABA_A receptor; mouse; cerebellum; radioligand; benzodiazepine; inhibitory current; locomotor activity; rotarod

	INTRODUCTION

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

The GABAergic system is the major contributor of the inhibitory tone throughout the CNS. GABA_A receptors are ligand-gated ion channels that exist as a number of different subtypes. The GABA_A receptor is a pentameric structure, which is formed by the coassembly of subunit polypeptides that exist in a large multigene family (McKernan and Whiting, 1996; Barnard et al., 1998). There are at least 16 different members of the GABA_A receptor gene family, including 6, 3, 3, , , , and  subunits (Whiting et al., 1999). The GABA_A receptor genes are differentially expressed both temporally and spatially throughout the mammalian brain. For example the 2, 3, and 3 subunits are the major  and  subunits in the fetal brain, respectively, whereas the 1 and 2 subunits are mainly expressed after birth (Zhang et al., 1991; Laurie et al., 1992b). Therefore, in the adult brain the 122 subtype is the major subtype accounting for ~43% of all GABA_A receptors, whereas the remaining receptors are made up mostly by 2- and 3-containing receptors together with other combinations of quantitatively more minor GABA_A receptor subtypes (McKernan and Whiting, 1996).

Several mouse strains lacking individual GABA_A receptor subunits have been generated to study the physiological role of GABAergic system in the living organism. Mice lacking the 2 subunit die shortly after birth (Gunther et al., 1995), whereas heterozygotes have a normal life expectancy and demonstrate neophobia in a novel environment (Crestani et al., 1999). The lethality of the 2/ mice can be rescued by transgenic overexpression of either the 2S or 2L subunit isoforms of the GABA_A receptor indicating that both 2 subunit splice variants can substitute for each other (Baer et al., 2000; Wick et al., 2000). Mice lacking the 3 subunit of the GABA_A receptor have cleft palate, epilepsy, and many behavioral characteristics of Angelman syndrome (Culiat et al., 1995; Homanics et al., 1997; DeLorey et al., 1998). Most of the 3/ mice die as neonates, but the survivors, which are runted until weaning, can achieve normal body size by adulthood. In contrast, mice lacking the 6 subunit of the GABA_A receptor, which is expressed exclusively in cerebellar granule cells, have no major phenotypic abnormalities (Jones et al., 1997). Expression of the  subunit is inhibited in the 6/ mice, suggesting that both subunits form functional GABA_A receptor subtypes in the cerebellar granule cells. Finally, mice deficient for the  subunit are viable but show attenuated sensitivity to neuroactive steroids and epileptic seizures (Mihalek et al., 1999).

GABA_A receptors are the site of action of a number of clinically important drugs, including benzodiazepines, barbiturates, and anesthetics (Sieghart, 1995; Whiting et al., 1995). The 122 subtype is of particular interest in this context because it comprises the major benzodiazepine binding site in the brain. We addressed the question about the physiological role of this receptor subtype by generating mice lacking either the 1 or 2 subunit of the GABA_A receptor which are thought to primarily coassemble to form the 122 subtype.

	MATERIALS AND METHODS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Generation of 1/ mice. The GABA_A receptor 1 gene-targeting vector was constructed from the same genomic 129/SvEv  fixII clone, which has been used for the introduction of the 1H101R mutation (McKernan et al., 2000). However, for the complete gene knock-out, exon 4 was disrupted at the MscI restriction site by cloning the 1.2 kb BstBI+MscI and the 7 kb EcoRV+BamHI DNA fragment blunt-ended into the targeting vector. A phosphoglycerate kinase I (PGK) neo and a thymidine kinase (TK) cassette were also engineered blunt-ended into the loxP site containing targeting vector. After linearization with NotI the targeting vector was introduced into AB2.2 embryonic stem (ES) cells (Lexicon Genetics) as described (Soriano et al., 1991; Rosahl et al., 1993, 1995). Homologous recombinants were identified by PCR using the primers 5'-ATTAATGGAGAGTGTGGTAATCTTT-3' and 5'-GGATGCGGTGGGCTCTATGGCTTCTGA-3' and were further confirmed by genomic Southern blotting. Correctly targeted ES cell clones were injected into C57BL6 blastocysts, and one of three clones gave rise to highly chimeric males, which transmitted the targeted allele into the germ line. A colony of homozygous and wild-type control animals were established and used for the present study. Some 1/ mice were crossed with a cre-transgenic mouse (Schwenk et al., 1995) and further interbred to establish 1 homozygotes, which no longer contained the neomycin resistance gene marker.

Mice lacking the 2 subunit were generated in a similar way. A 17.5 kb genomic /FixII clone containing exons 6, 7, and 8 of the 2 subunit was subcloned into pBluescript via the NotI sites. An 8.5 kb SalI DNA fragment as a long arm and a 1.25 kb HpaI + FspI DNA fragment as a short arm were cloned into the PGK neo and TK containing modified pBS246 plasmid (T. W. Rosahl and K. L. Hadingham, unpublished observations) resulting in the deletion of exons 6 and 7 in the targeting vector. After linearization of the targeting vector with NotI and introduction into AB2.2 ES cells, homologous recombinants were identified using the following PCR primers: 5'-ACCAGTCTGGACCATGAGTTCCCA-3' and 5'-GGATGCGGTGGGCTCTATGGCTTCTGA-3' One of three injected ES cell clones gave rise to a chimera transmitting the gene disruption into the germ line. A colony of 2/ mice containing the neo gene and some neo gene by crossing with the deleter mice were generated as for the 1/ mice.

Radioligand binding and biochemical analysis. Radioligand binding assays with [³H]Ro15-1788 (87 Ci/mmol; NEN Life Sciences), [³H]Ro15-4513 (21.7 Ci/mmol; NEN Life Sciences) in the presence or absence of 10 µM diazepam and [³H]muscimol (19.1 Ci/mmol; NEN Life Sciences) were performed on membrane preparations as previously described (Quirk et al., 1994; Sur et al., 1998, 1999a).

Autoradiographic studies of the convulsant binding site of GABA_A receptors were performed using 8 nM [³⁵S]t-butylbicyclophosphorothionate (TBPS) on coronal sections of wild-type and knock-out mouse brains cut at a thickness of 12-16 µm. Sections were washed in 50 mM Triscitrate and 200 mM NaBr, pH 7.4, buffer for 10 min and then incubated in the same buffer containing [³⁵S]TBPS or [³⁵S]TBPS plus 10 µM picrotoxin for nonspecific binding for 90 min at room temperature. Slides were washed twice for 5 min in cold buffer, rinsed in distilled water, and exposed to film for 48 hr.

Autoradiographic analyses of the different benzodiazepine-binding sites were done as previously described (Turner et al., 1991; Sur et al., 1999b) with 2 nM [³H]Ro15-1788 (labels 12, 22, and 32 subtypes), 4 nM [³H]L-655,708 plus 10 µM zolpidem (labels 52 subtype), and 8 nM [³H]Ro15-4513 plus 20 µM diazepam (labels 42 and 62 subtypes) on coronal sections (12-16 µm) from two to four mice per genotype. After 3-8 weeks exposure, autoradiograms were analyzed with a Micro Computer Imaging Device M2 imaging system (Imaging Research, St. Catharines, Ontario, Canada).

Immunoprecipitation studies with selective 1, 2, and 3 antibodies were performed on solubilized receptors as previously described (McKernan et al., 1991) using a 10 nM concentration of [³H]Ro15-1788.

For Western blot analyses of 30 µg of protein were loaded on a 4-12% Bis-Tris gel (Novex, San Diego, CA). Proteins were then transferred to nitrocellulose membrane (Hybond-C; Amersham Pharmacia Biotech, Little Chalfont, UK) by semidry blotting, and the presence of 1 and 3 subunit was detected by incubation with specific rabbit anti-1 (10 µg/ml) and anti-3 (7 µg/ml) antibodies and the ECL detection system (Amersham Pharmacia Biotech).

Data analyses and statistics were performed with GraphPad Prism (San Diego, CA).

Electrophysiology. Cerebellum was removed from 1/, 2/, and wild-type mice at postnatal days 11-17, and the vermal layer was isolated and placed into ice-cold oxygenated dissociation media containing (in mM): 82 Na₂SO₄, 30 K₂SO₄, 5 MgCl₂, 10 HEPES buffer, and 10 glucose at pH 7.4. Tissue was then stirred for 7 min in 10 ml of dissociation media containing 3 mg/ml of protease XXIII (Sigma) at 37°C. The tissue was then washed in warmed oxygenated dissociation media containing 1 mg/ml bovine serum albumin and 1 mg/ml trypsin inhibitor and maintained under oxygenating conditions at room temperature in Tyrode's solution (in mM: 150 NaCl, 4 KCl, 2 CaCl₂, 2 MgCl₂, 10 HEPES, and 10 glucose, pH 7.4). Tissue was withdrawn as needed and triturated with a fire-polished Pasteur pipette to liberate individual cells. Cells were plated onto a glass coverslip and left to settle for at least 30 min before use. Purkinje cell bodies were identified by their characteristic size and morphology. Cells could be used for up to 5 hr after preparation.

Glass coverslips containing the dissociated cells were placed in a perspex recording chamber on the stage of a Nikon Diaphot inverted microscope. Cells were perfused continuously with artificial CSF (aCSF) containing (in mM): 149 NaCl, 3.25 KCl, 2 CaCl₂, 2 MgCl₂, 10 HEPES, 11 D-glucose, D(+)-sucrose, pH 7.4, and observed with phase-contrast optics. Fire-polished patch pipettes were pulled on a WZ, DMZ-Universal puller (Zeitz-Instruments, Munich, Germany) using conventional 120TF-10 electrode glass. Pipette tip diameter was ~1.5-2.5 µM, with resistances ~4 M. The intracellular solution contained (in mM): 130 CsCl, 10 HEPES, 10 BAPTA-Cs, 5 ATP-Mg, 0.1 leupeptin, and 1 MgCl₂, with 100 µM NaCO₃, pH-adjusted to 7.3 with CsOH and 320-340 mOsm. Cells were voltage-clamped at 60 mV using an Axopatch 200B amplifier (Axon Instruments, Foster City, CA). Drug solutions were applied to the cells via a multibarrel drug delivery system, which could pivot the barrels into place using a stepping motor. This ensured rapid application and washout of the drug. Drugs were applied to the cell for 5 sec with a 30 sec washout period between applications. Allosteric potentiation of GABA_A receptors was measured relative to a GABA EC₂₀ determined for each cell to account for differences in GABA potency. Modulators were pre-equilibrated for 30 sec before coapplication of GABA.

Behavioral analysis. All mice tested were in a 50% C57BL6, 50% 129SvEv background. They were housed in groups under standard 12 hr light/dark cycle and had ad libitum access to standard mouse diet and water. Two- to 3-month-old F4 generation mice were tested for motor coordination on the rotarod, and 6-month-old F5 mice were used to determine spontaneous locomotor activity.

Motor coordination was assessed using the rotarod test. Wild-type (n = 9), 1/ (n = 7), and 2/ (n = 6) mice were first trained until they could remain on a rotarod revolving at 16 rpm for three consecutive 120 sec trials. The next day the mice were placed back on the rotarod for a single trial at 18 rpm (maximum duration 120 sec). The duration a mouse could remain on the rotarod was recorded, and the mouse was then returned to its home cage. The speed of the rotarod was then increased to 21 rpm, and all mice were given another test trial. This process was repeated for rotarod speeds of 24, 27, 30, 33, and 36 rpm. Spontaneous locomotor activity was measured using individual perspex activity chambers (215 × 270 × 210 mm) equipped with two parallel infrared beams running across each end of the base of the chamber. Naive 1/ and wild-type mice (n = 10 per group) were placed in the activity cages, and cage crosses (i.e., consecutive breaks of each beam) were measured for 1 hr. In a separate experiment naive 2/ and wild-type mice (n = 12 per group) were also assessed for spontaneous locomotor activity for 1 hr. Data were analyzed using a repeated measures ANOVA, and then individual time bins were examined with a two-way ANOVA.

	RESULTS

TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES

Generation of 1/ and 2/ mice

Exon 4 of the 1 subunit gene of the GABA_A receptor was disrupted, and exons 6 and 7 of the 2 subunit gene were deleted in mice by the homologous recombination technique (Rosahl et al., 1993, 1995; McKernan et al., 2000) (Fig. 1a-h). A colony of 1/ and 2/ mice were bred and analyzed, whereas the neomycin resistance gene flanked by loxP sites (Fig. 1c,g, floxed) remained in the targeted locus. These 1 or 2/ [+neo] mice were kept in a ~50% C57BL6-50% 129SvEv genetic background. Some homozygotes of the F3 generation were crossed with the cre containing "deleter" mouse (Schwenk et al., 1995) to remove the neo gene in the offspring (Fig. 1d,h). This resulted in a change of the genetic background to ~75% C57BL6-25% 129SvEv. The heterozygous offspring was interbred to produce 1 or 2/ [neo] and wild-type control mice. Northern blot results using a 45 mer antisense oligonucleotide specific for exon 4 upstream of the gene disruption confirmed complete absence of 1 mRNA in both the 1/ [+neo] and 1/ [neo] mice (Fig. 1i). Similarly, a probe for the 5' part of the 2 subunit gene demonstrated lack of any 2 mRNA in the 2/ [+neo] and 2/ [-neo] mice. No major changes in the expression of the 3, 6, 3, and 2 genes were found in either knock-out mouse lines regardless of the presence or absence of the neo gene (Fig. 1i) (data not shown). Therefore, all experiments presented in Figures 1j-6 were performed on 1/ or 2/ mice containing the neomycin resistance gene. The complete loss of 1 protein in 1/ [+neo] mice was further substantiated by the absence of a major 50 kDa band on Western blots (Fig. 1j). Absence of the 2 subunit protein in the 2/ mice could not be confirmed by Western blotting because no antibody specific for the 2 subunit was available.

View larger version (26K): [in this window] [in a new window]   Figure 1.   Generation and validation of 1 and 2 / mice. a, b, e, f, Schematic representation of the WT 1 (a, b) and 2 allele (e, f) of the GABAA receptor and the corresponding targeting vectors. 4, 6, 7, Exons 4, 6, and 7, respectively; 4, partial deletion of exon 4; neo, neomycin resistance gene; TK, thymidine kinase gene; E, EcoRI restriction site; K, KpnI restriction site; P1, P2, P3, P4, PCR primers for detecting the mutant 1 and 2 allele, respectively. c, g, Targeted allele after homologous recombination for 1 and for 2 allele, and after cre-mediated removal of the neomycin resistance gene (d, h), respectively. i, Northern blot results using 45 mer oligonucleotides for the 1, 3, 6, 2, and 3 subunit genes of the GABAA receptor and neomycin resistance (neo) and glyceraldehyde-3-phosphate dehydrogenase gene as probes; 5 µg of poly(A+) selected RNA was loaded per lane; 1+/+ and 2+/+: wild-type control samples; 1/[-neo] and 2/[-neo]: samples from 1 and 2 homozygotes lacking the neo gene in their genome; 1/[+neo] and 2/[+neo]: samples from 1 and 2 homozygotes with the neo gene in their genome. j, Western blot demonstrating the absence of 1 polypeptide in the brain of 1/ mice.

Pharmacological characterization of GABA_A receptors in 1 / and 2 / mice

Autoradiography with [³⁵S]TBPS, a radioligand that binds to a site putatively located to the channel pore of all GABA_A receptors (Luddens and Korpi, 1995), confirmed a large and widespread loss of GABA_A receptors in cortex (66 and 46%), septum (53 and 60%), caudate putamen (40 and 37%), globus pallidus (72 and 74%), hippocampus (53 and 27%), thalamus (65 and 63%), and cerebellum (67 and 71%) of both 1/and 2/ mice, respectively (Fig. 2). These losses were further demonstrated by the 66 and 58% reduction in the total number of GABA_A receptors, as measured by the binding of [³H]muscimol to membranes from the brains of 1/ and 2 / mice (Table 1). Saturation experiments revealed a large reduction in [³H]Ro15-1788 binding sites in the forebrain of 1/ (57 ± 4%; n = 3) and 2/ (51 ± 4%; n = 4) compared with wild-type mice with no change in the affinity of the radioligand (Tables 1, 2). The expression of [³H]Ro15-1788 binding sites was also reduced in the cerebellum of 1/ (67 ± 3%; n = 3) and 2/ (71 ± 5%; n = 4) animals. Surprisingly the reduction of [³H]Ro15-1788 binding in the cerebellum of 1/ mice was less than expected because the 12 subtype is reported to be the main benzodiazepine-sensitive GABA_A receptor in this brain region, accounting for 90 ± 3% (n = 4) of total [³H]Ro15-1788 sites, as determined by immunoprecipitation with an 1-specific antisera. Additional immunoprecipitation experiments with an 3 subunit-specific antisera indicated that in wild-type mice the remaining cerebellar [³H]Ro15-1788 binding sites (14 ± 3%; n = 3) are contributed by 32 receptors. These observations pointed toward a putative upregulation of 3 subunit containing GABA_A receptors in the cerebellum of 1/ mice (see below). Radioligand inhibition binding studies with [³H]Ro15-1788 and a number of benzodiazepine site compounds revealed no significant (Student's t test, unpaired, two-tailed) changes in the pharmacology of the remaining GABA_A receptors in both 1/ and 2/ mouse lines (Table 2) with the exception of the complete loss of high-affinity binding sites for zolpidem, an 1-selective compound (Sieghart, 1995), in 1/ mice whereas high-affinity zolpidem binding sites still accounted for 49% of total [³H]Ro15-1788 sites in 2/ brains (Table 2).

View larger version (114K): [in this window] [in a new window]   Figure 2.   Loss of GABAA receptors in the forebrain and cerebellum of 1 / and 2 / mice. Color-coded autoradiograms for [35S]TBPS (8 nM) binding to sections of mouse brain revealed a widespread reduction of GABAA receptors. Major losses are observed in cortex (66 and 46%), globus pallidus (72 and 74%), thalamus (65 and 63%), and cerebellum (67 and 71%) for example of 1 / and 2 / mice, respectively. Scale bars, 1 mm.

View this table: [in this window] [in a new window]   Table 1.   Amount (fmol/mg protein) of GABAA receptors and benzodiazepine binding sites in WT, 1/, and 2/ mice determined by nonlinear regression analysis of saturation data sets

View this table: [in this window] [in a new window]   Table 2.   Pharmacological characterization of GABAA receptors in WT, 1 (/), and 2 (/) mice

Electrophysiological analyses of GABA_A receptors in Purkinje neurons of 1/ and 2/ mice

Cerebellar Purkinje neurons have been shown to express a limited repertoire of GABA_A receptor subunits, predominantly consisting of 122 (Laurie et al., 1992a; Persohn et al., 1992; Fritschy and Mohler, 1995). These cells then provided an ideal candidate for the study of the effects of elimination of the 1 or the 2 subunits by gene targeting. Whole-cell patch-clamp recordings were made from dissociated cerebellar Purkinje neurons isolated from both the 1/ and 2/ mice and compared with those of wild-type littermates. Recordings from wild-type neurons revealed the presence of robust GABA-mediated currents in all cells tested with a mean amplitude of 2982 ± 271 nA (n = 30) (Fig. 3a) in response to 1 mM GABA application. GABA EC₂₀ currents were significantly enhanced by the benzodiazepine modulators chlordiazepoxide (148 ± 8% at 3 µM; n = 20) and the 1-selective compound zolpidem (182 ± 13% at 100 nM; n = 17) (Fig. 3a,b). In contrast, 23 of 52 of the cells from the 1/ mice did not produce a response to 1 mM GABA. In those cells that did respond to GABA, these currents were significantly reduced in amplitude (mean of 52 cells, 257 ± 54 pA). Comparing measured EC₂₀ values in these cells also demonstrated a significant decrease in the potency of GABA in the 1/ cells [3.8 ± 0.3 µM (20) in wild-type and 19.0 ± 4.6 µM (5) in 1/]. Of those cells with GABA currents large enough to measure an EC₂₀ response, five were studied using the benzodiazepine modulators. The potentiation by chlordiazepoxide was identical to that in wild-type animals (138 ± 35%), however the effect of 100 nM zolpidem was markedly reduced (34 ± 17%), suggesting that these receptors contained either 2 or 3 subunits or are formed from 22 alone. Similar experiments using the 2/ animals revealed a different profile. In contrast to the 1/ mice, every cell responded to GABA, however the mean current amplitude was reduced compared with wild-type (1234 ± 144 pA; n = 13). As with the 1/ mice the potentiation of the GABA currents of Purkinje cells from 2/ mice by chlordiazepoxide was similar to wild-type (104 ± 17%; n = 6), however there was marked potentiation produced by 100 nM zolpidem (108 ± 15%; n = 5). The effect of zolpidem was significantly reduced compared with wild-type mice, suggesting that the receptors present contain a mixed population of 1x2 and 2/3x2. To determine the -isoform present in the receptors in the 2/ mice, the effects of the -subunit-selective agents loreclezole and etomidate were investigated. These compounds selectively potentiate receptors containing a 2 or 3 subunit, but not 1-containing receptors (Wafford et al., 1994; Hill-Venning et al., 1997). Robust potentiation of the GABA EC₂₀ by both agents was observed in both the wild-type and 2/ mice (Fig. 4), suggesting that the remaining receptors expressed in Purkinje contained predominantly 3 subunits.

View larger version (25K): [in this window] [in a new window]   Figure 3.   Electrophysiological analysis of GABA currents recorded from cerebellar Purkinje neurons of wild-type and 1/ and 2/ mice. a, Example recordings from wild-type (WT), 1/, and 2/ mice, of the response to 1 mM GABA, and potentiation of submaximal, EC20 currents by 3 µM chlordiazepoxide or 100 nM zolpidem (this concentration would distinguish 1 from other subtypes). Amplitude is indicated by the scale bar in each case, and drugs were applied as shown by the bar above each response. B, Mean current amplitude in response to 1 mM GABA from isolated Purkinje neurons; n number is shown in parentheses above each column and includes all cells tested including unresponsive cells. c, Mean potentiation of GABA EC20 by 3 µM chordiazepoxide; n number is shown in parentheses above each column. d, Mean potentiation of GABA EC20 by 100 nM zolpidem; n number is shown in parentheses above each column.

View larger version (21K): [in this window] [in a new window]   Figure 4.   Effects of loreclezole, etomidate, and pentobarbital on GABA receptors from WT and 2/ Purkinje neurons. a, Recording from WT and 2/ neurons showing a GABA response to 1 mM GABA followed by the potentiation of a GABA EC20 response by 3 µM loreclezole, 30 µM etomidate, and 100 µM pentobarbital. Amplitude is indicated by the scale bar, and drugs were applied as shown by the bar above each response. b-d, Mean potentiation of the GABA EC20 response by 3 µM loreclezole (b), 30 µM etomidate (c), and 100 µM pentobarbital (d); n number is shown in parentheses above each column.

Behavioral phenotype of 1/ and 2/ mice

After breeding of 1 heterozygotes of the F1 generation, 1 / mice were found to be under-represented in the F2 generation, accounting for only 13.4% of all offspring (29 1/ of 217 pups in total). The surviving 1 homozygotes appeared to have lower body weights and were less well groomed before weaning, but improved their appearance with age. Therefore, the behavioral analysis focused on adult animals only. The 2/ mice were represented in a Mendelian manner in the F2 generation (23 of 95 animals in total) and had no obvious phenotypical abnormalities.

A neurological screen was initially performed on adult F2 mice to determine whether there were any major neurological deficits in these animals. Neither 1/ nor 2/ mice displayed any major deficits on beam balancing and swimming ability tests (data not shown). Two-month-old 1/ were smaller and had lower body weights (~30%) than wild-type controls, and this difference persisted until at least 3 months of age. 1/ mice were also observed to have a tremor when handled, but this did not impair their ability to perform motor tasks. 2/ mice had normal body weights (data not shown).

A more detailed assessment of motor coordination was performed using the rotarod. A two-factor repeated measures ANOVA indicated that both 1/ and 2/ mice were as capable of remaining on the rotarod as wild-type controls (genotype: F_(2,19) = 0.05; p = 0.95) (Fig. 5a). As expected, performance declined as the revolution speed increased (speed: F_(6,114) = 22.73; p < 0.00005), but there were no deficits seen in either of the knock-out lines. 1/ mice displayed a similar level of spontaneous locomotor activity and exploration compared with wild-types (Fig. 5b) when placed in the novel environment of activity chambers (genotype: F_(1,18) = 0.02; p = 0.66; repeated measures ANOVA). They also habituated to this environment over a similar time scale as wild-types (time × genotype interaction: F_(29,522) = 0.90; p = 0.51). In contrast, 2/ animals (Fig. 5c) exhibited a much higher level of activity in this test (genotype: F_(1,22) = 10.63; p = 0.0036), although they did habituate to a similar degree as wild-types (time × genotype interaction: F_(29,638) = 0.72; p = 0.86).

View larger version (16K): [in this window] [in a new window]   Figure 5.   Behavioral evaluation of 1 and 2 / mice. a, The duration a mouse remained walking on the rotarod revolving at different speeds (18-36 rpm) decreased as the speed was increased. 1 and 2 / mice did not differ from wild-type mice at any speed examined. Data are the means ± SEM; n = 6-9. The spontaneous locomotor activity of 1 / mice (b) did not differ from wild-type mice. In contrast, 2 / mice (c) showed a marked increase in activity (p < 0.005) compared with wild-type mice. Data are the mean number of cage crosses in 2 min time bins ± SEM; n = 10-12.

Generation-dependent litter size and upregulation of 2 and 3 subunits in 1/ mice

To establish an 1/ mouse line, homozygotes of the F2 generation were interbred using a variety of breeding pairs and avoiding any brother-sister matings. Similarly, 2/ and wild-type control lines originating from their F2 littermates were established. However, there were some indications that the 1/ surviving pups appeared to be phenotypically less affected in the F4 and F5 generation in comparison with the initial findings of the 1 homozygotes in the F2 generation. Therefore, we analyzed the number of pups in each litter for the 1/ mouse line in detail. The litter size from wild-type matings remained constant at approximately seven pups per litter between the F3 and F5 generations (Table 3). In contrast, F2 1/ matings produced significantly smaller litters (approximately three pups per litter), but litter size increased with increasing generation number.

View this table: [in this window] [in a new window]   Table 3.   Litter size increases across several generations

The possibility that this generation-dependent phenotypic change is paralleled by modification in GABA_A receptor expression was investigated with [³H]Ro15-1788 saturation binding, a radioligand that would likely detect upregulation or downregulation of GABA_A receptors (Fig. 6a,b). Indeed, in the cerebellum of 1/ mice, a generation-dependent reduction in the amount of GABA_A receptors was observed. Specifically, the loss of total [³H]Ro15-1788 binding sites determined by Scatchard analyses was increased from generation F2 (49%; n = 1) to generation F3 (67 ± 3%; n = 3). The reduction in generation F3 was significantly different (p < 0.001; Student's t test) from generation F5 (87 ± 1%; n = 4) which was equivalent to the amount of wild-type cerebellar 1 receptors sensitive to Ro15-1788 (90 ± 3%; n = 4), as determined by immunoprecipitation with an 1-specific antibody (Fig. 6a). The last observation indicated that in F5 generation mice there is no longer an upregulation of benzodiazepine-sensitive GABA_A receptors. A similar trend was demonstrated in forebrains of 1/ mice where reduction in [³H]Ro15-1788 sites increased from 45% (n = 1) in generation F2 to 57 ± 4% (n = 3) in generation F3, and finally reached 66 ± 2% (n = 4) in generation F5. In this F5 generation, no upregulation of [³H]Ro15-1788 sites occurred because the recorded reduction was similar to the number of wild-type forebrain 1 receptors sensitive to Ro15-1788 (67 ± 3%; n = 4) determined by immunoprecipitation as well as the proportion of high-affinity zolpidem binding sites (62 ± 15%; n = 4) found in wild-type mouse (Fig. 6b, Table 2). To determine which GABA_A receptor subtype was responsible for this upregulation in the F3 generation, we focused our attention on 2 and 3 subunits that are the most abundantly expressed subunits after the 1 subunit in adult brain and also the predominant embryonic isoforms (Laurie et al., 1992b). In cerebellum, Western blot analyses revealed a marked increased in the expression of 3 subunit in 1/ compared with wild-type mice (Fig. 6c). The faint band observed in wild-type cerebellum is in agreement with 3 receptors accounting for 14 ± 3% (n = 3) of total [³H]Ro15-1788 binding sites in this brain region. Furthermore, quantitative immunoprecipitation experiments allowed us to demonstrate that an 3 subunit-specific antisera precipitated all (92 ± 8%; n = 4) available [³H]Ro15-1788 binding sites (Fig. 6c). These results indicated that upregulation of 3 subunit in the cerebellum of 1/ is solely responsible for the increase in total [³H]Ro15-1788 sites observed in F3 generation. The contribution of 2 and 3 subunits in the upregulation of [³H]Ro15-1788 binding sites in the forebrain of 1/ mice was investigated by quantitative immunoprecipitation. Results showed that 2 and 3 subunits account for 17 ± 3% (n = 4) and 14 ± 4% (n = 4) of total [³H]Ro15-1788 sites in wild-type mice, respectively, and their respective contribution increased to 56 ± 7% (n = 4) and 45 ± 7% (n = 4) in 1/ animals. Given that the total number of [³H]Ro15-1788 sites in the forebrain of F3 generation 1/ mice has been shown to represent 43% of that in wild-type mice (Table 1), a net increase of 42% in the expression of both 2 and 3 subunits was estimated (Fig. 6d). Putative changes in the expression of minor populations of GABA_A receptors were also investigated by various pharmacological approaches. Quantitative autoradiography with [³H]L-655,708, a 5 subtype-selective ligand, revealed no change in expression of this subunit in CA1-CA3 fields of hippocampus (96% of wild-type), dentate gyrus (99% of wild-type), and endopiriform nucleus (99% of wild-type) (Table 4). Similar autoradiography experiments with [³H]Ro15-4513 plus 20 µM diazepam showed no changes in the expression of 42 receptors in the thalamus, hippocampus, and cortex of 1/ mice. However, binding experiments with 40 nM [³H]Ro15-4513 plus 10 µM diazepam on cerebellar membranes from F5 generation 1/ mice demonstrated a significant reduction (38 ± 10%; n = 4) in the expression of 6 receptors (Table 4). This reduction did not result from the presence of the neomycin cassette in the targeted gene because a similar (p > 0.42; Student's t test) 26 ± 10% (n = 4) reduction in 6 subunit expression was determined in the cerebellum of F6 generation cre-excised 1/ [neo] mice.

View larger version (37K): [in this window] [in a new window]   Figure 6.   Generation-dependent upregulation of 2 and 3 subunits in cerebellum and forebrain of 1/ mice. a, The loss of [3H]Ro15-1788 binding sites increased in cerebellum (left panel) and forebrain (right panel) of 1/ mice from generation F2 to F5 to finally reach the proportion of [3H]Ro15-1788 sites immunoprecipitated by a selective 1 antibody from wild-type membrane (filled bars). ***p < 0.001; Student's t test. b, Evidence for an upregulation of 3 subunit in the cerebellum of 1/ mice. Western blot showing an increase in 3 subunit expression in knock-out mice compared with wild-type (left panel). Quantitative immunoprecipitation with a 3 antibody demonstrated that 3 subunit-containing GABAA receptors account for 14 ± 3% (mean ± SEM; n = 3) and 92 ± 8% (mean ± SEM; n = 4) of total [3H]Ro15-1788 binding sites in the cerebellum of wild-type and 1/ mice, respectively (right panel). c, Quantitative immunoprecipitation demonstrated a 42% increase in the expression of 2 and 3 subunit-sensitive [3H]Ro15-1788 binding sites in the forebrain of 1/ compared with wild-type mice.

View this table: [in this window] [in a new window]   Table 4.   Variation in the expression of various GABAA receptor subtypes in 1/ and 2/ mice

Effect of deletion of the 2 subunit gene on the expression of the various  subunits

To determine whether the compensatory changes in subunit expression observed in 1/ mice were because of the loss of 1 subunit or the loss of the 122 receptor per se, the expression of the various  subunits was investigated in the 2/ mice. Immunoprecipitation experiments indicated that 1, 2, and 3 subunits represented 54 ± 12% (n = 4), 18 ± 5% (n = 4), and 11 ± 1% (n = 4) of total forebrain [³H]Ro15-1788 binding sites from 2/ mice, respectively. These proportions equated to a reduction by 60, 48, and 69% of 1, 2, and 3 subunit-containing receptors (Table 4), given the fact that in 2/ brains the [³H]Ro15-1788 binding sites represent only 49% (Table 1) of the wild-type complement. Quantitative autoradiography using the 5 subtype-selective ligand [³H]L-655,708 revealed an overall 39% reduction in the expression of 5 subunit with losses of 33% in the hippocampus and 53% in the endopiriform nucleus. Similar experiments with [³H]Ro15-4513 plus 20 µM diazepam revealed significant losses of 42 receptors in various regions such as the cortex (55%), the hippocampus (50%), and the thalamus (59%). Radioligand binding experiments on mice forebrain with 40 nM [³H]Ro15-4513 plus 10 µM diazepam confirmed these autoradiographic measures and demonstrated an overall 60 ± 7% (n = 5) decrease in 4-containing receptors (Table 4). Finally, the expression of diazepam-insensitive [³H]Ro15-4513 receptors in the cerebellum of 2/ mice was reduced by 62 ± 6% (n = 5) (Table 4). This downregulation of 6 receptors was again independent of the presence of the neomycin cassette in the targeted gene because diazepam-insensitive [³H]Ro15-4513 sites were also decreased by 80 ± 3% (n = 2) in the cerebellum of 2/ [neo] mice.

	DISCUSSION

TOP